People: EOS Imaging SA (EOSI.PA)

EOSI.PA on Paris Stock Exchange

5.17EUR
19 Dec 2014
Price Change (% chg)

€0.08 (+1.57%)
Prev Close
€5.09
Open
€5.07
Day's High
€5.17
Day's Low
€4.98
Volume
19,245
Avg. Vol
32,230
52-wk High
€8.36
52-wk Low
€4.46

Search Stocks

Summary

Name Age Since Current Position

Michael Dormer

57 2012 Chairman of the Board

Marie Meynadier

2010 Chief Executive Officer, Director

Herve Legrand

Deputy Chief Executive Officer, Director of Sales and Marketing for North America and Director

Anne Renevot

Chief Financial Officer, Chief Administrative Officer

Sebastien Henry

Chief Executive Officer - OneFIT Medical

Didier Saint-Felix

Director of Operations

Maurice Deplanque

Director of Research and Development

Eric Maulave

2013 Vice President of International Sales

Karine Chevrie

2006 Director of Quality and Regulatory Affairs

Eric Beard

2012 Director

Aris Constantinides

2011 Director - Representative of NBGI Private Equity

Marie-Laure Garrigues

2011 Director - Representative of CDC Enterprises

Stephane Sallmard

2012 Director

Philip Whitehead

2010 Director

Raphael Wisniewski

42 2012 Director - Representative of Edmond de Rothschild Investment Partners

Biographies

Name Description

Michael Dormer

Mr. Michael J. Dormer was appointed Chairman of the Board of EOS Imaging SA on November 9, 2012. He has more than 30 years experience in medical devices and more specifically orthopaedics, in which he has held a number of high-ranking positions. He joined Johnson & Johnson in 1976 before moving to De Puy in 1992, where he served as President and oversaw the company’s IPO in 1996. Following the acquisition of De Puy by Johnson & Johnson, he became Chairman of the Medical Devices and Diagnostics division at Johnson & Johnson. He is currently a director of Jenavalve, Endosense and Chairman and Managing Director of Neoss Ltd.

Marie Meynadier

Dr. Marie Meynadier serves as Chief Executive Officer and Director at EOS Imaging SA since April 9, 2010. After her doctorate she joined Bellcore (Red Bank, NJ) and ATT Bell Labs (Murray Hill, NJ) where she conducted research on semiconductor devices. Back in France, she took over the management of programs of national and international development in electronics, optics and microelectronics that enabled the creation of several start-ups in these areas. She joined the medical field in 1999, taking charge of the start-up Biospace lab specializing in preclinical imaging. Dr. Maynadier holds a degree in electronic engineering from Ecole Superieure des Telecommunications and a Ph.D. from the Ecole Normale Superieure. She is Director of EOS Imaging Inc and EOS Imaging GmbH.

Herve Legrand

Mr. Herve Legrand serves as Deputy Chief Executive Officer, Director of Sales and Marketing for North America and Director at EOS Imaging SA. He has over 15 years experience in the medical field. He began his career in marketing in the pharmaceutical industry at Synthelabo, then joined corporate sector of orthopedics. Prior to joining EOS imaging, he spent nine years at Stryker in Switzerland, first in charge of international marketing Trauma division then he obtained more strategic roles in EMEA for Stryker Trauma. Mr. Legrand has a degree in biochemistry and molecular genetics and a Master in Marketing from the University of Paris XIII. He is currently Chairman of Advanced Cardiac Therapeutics Inc and Director of 2010 Perfect Vision AG, DysisMedical Ltd, Endoscopic Technologies Inc, SuperSonic Imagine SA and Marshalsea Road Management Company.

Anne Renevot

Ms. Anne Renevot is Chief Financial Officer and Chief Administrative Officer at EOS Imaging SA. She has 18 years' experience in Finance. She began her career with the Legris Industries group as Controller and then joined Ernst & Young Audit in Paris as Manager. She has been appointed Chief Executive Officer in several sectors, including luxury products (Cartier) and online gaming (Gametap-Metaboli) on both local and international markets. She graduated from Audencia Management School. She joined EOS imaging in 2011.

Sebastien Henry

Mr. Sebastien Henry is Chief Executive Officer of OneFIT Medical, a subsidiary of EOS Imaging SA. He has founded the OneFIT group in November 2013. He has 16 years of experience in orthopedics. He previously acted as Business Development Manager Europe of Zimmer.

Didier Saint-Felix

Mr. Didier Saint-Felix is Director of Operations at EOS Imaging SA. He has over 30 years' experience in the Research and Development of medical imaging systems. With a diploma in electrical engineering from the Ecole Nationale Superieure d’Electricite and a doctorate in signal processing, Mr. Saint-Felix began his career at the CNRS and then in 1986 joined General Electric Healthcare to develop the first 3D angiography system used with a 2D detector, a system which is now in daily clinical use. He then led the research and development into mammography at GE, to completely renew the product line and introduce digital technology. He is also a specialist in the quality and regulations applied to medical imaging. He joined EOS imaging in 2006 to adapt the EOS prototype to an industrial and commercial setting and organise the necessary development, production and service.

Maurice Deplanque

Mr. Maurice Deplanque is Director of Research and Development at EOS Imaging SA. He joined General Electric Healthcare in 1997 after completing his PhD studies. He is a certified Six Sigma Black Belt. He joined the Company in 2007.

Eric Maulave

Mr. Eric Maulave serves as Vice President of International Sales at EOS Imaging SA. He spent the last five years within the Philips Group’s Healthcare division, where he was in charge of sales and marketing for the X-ray unit for various regions and Home Healthcare solutions for emerging markets. He holds a MBA from the University of Hartford, Connecticut (USA). Mr. Maulave has experience in international markets and high-tech medical technologies.

Karine Chevrie

Ms. Karine Chevrie is Director of Quality and Regulatory Affairs at EOS Imaging SA. With a doctorate in biochemistry, she has 18 years' experience in the field of medical devices. After starting her career in marketing in the field of blood transfusion within the medical branch of the American group Pall, she joined the French agency for the safety of health products, Afssaps, upon its creation, with responsibility for medical devices with biological risks. In her seven years at Afssaps, she participated in various European Commission working groups and played an active role in the establishment of a regulatory framework aiming in particular to strengthen the health safety of medical devices within the context of the prion risk. She joined EOS imaging in 2006 at the beginning of its commercial structuring to take over management of regulatory affairs and quality.

Eric Beard

Mr. Eric Beard was appointed Director of EOS Imaging SA on June 29, 2012. He joined Baxter Healthcare in 1975, where he pursued an international career, principally in North America, Asia Pacific and Europe. He held various positions of increasing importance in finance and later was in charge of Baxter's renal products in various countries and regions. In 1999, he assumed global responsibility for the dialysis business as President. In 2001, he was appointed President of Baxter EMEA. He joined Sorin Group in 2003 as International President in charge of worldwide sales and marketing. He is currently Chairman of Cellnovo.

Aris Constantinides

Mr. Aris Constantinides serves as Director - Representative of NBGI Private Equity at EOS Imaging SA since June 30, 2011. He is the Founder and Investment Director of NBGI Ventures, and is responsible for its overall strategy and management. He serves on the board of a number of medtech companies including Bonesupport AB, Upfront Chromatography A/S, Supersonic Imagine SA Forth Photonics Limited, 2010 Perfect Vision and Reverse Medical Inc. He established NBGI Ventures in 2001, following five years in venture capital with Deutsche Bank’s venture capital team and CSFB’s Cabot Square Capital fund. He started his career at Bankers Trust as a derivatives specialist. Mr. Constantinides holds a Bachelors of Engineering from Imperial College in London and a SM from Massachusetts Institute of Technology (MIT) in Mechanical Engineering and an MBA from INSEAD.

Marie-Laure Garrigues

Ms. Marie-Laure Garrigues has served as Director - Representative of CDC Enterprises at EOS Imaging SA since December 2, 2011. She has been a Director of Investments at CDC Entreprises since 2008. Earlier in her career, she was the Microbiology Division Manager at Bio-Rad Laboratories, a California Diagnostics company, after moving from Sanofi Diagnostics Pasteur, where she held successive management positions in R&D, marketing and operations. Ms. Garrigues is a pharmacist, former Internist in Medical Biology and holds a DEA from the Faculty of Pharmacy of the University of Paris V.

Stephane Sallmard

Mr. Stephane Sallmard serves as Director of EOS Imaging SA since November 9, 2012. He previously served as Chairman of the Board of Directors. He started his career as a System Engineer at IBM France. He then assumed the position of Commercial and Service Director at Wang France and became Northern Europe Director of General Electric Medical System. During his time at Optos Plc as Chief Executive Officer and Director, he collected several technology awards and was among the finalists of the Manager of the Year 2004. Mr. Sallmard holds a diploma from Ecole Superieure d’Electricite Industrielle de Paris. He is Chairman of DySIS Medical Ltd , Imagine Eyes SARL and Director of i-Optics BV.

Philip Whitehead

Mr. Philip Whitehead serves as Director at EOS Imaging SA since December 6, 2010. He is Vice President of Danaher and Chief Executive Officer of Danaher Corporate Development in Europe. Mr. Whitehead joined Danaher in 1992 and has been responsible for running a number of Danaher’s European businesses before taking his current role in Corporate Development in September 2001. He is Director of Time Spent Property Developments Ltd, Linx Printing Technologies Ltd, Danaher UK Industries Ltd, Hoddington Inns Ltd, Hampshire Hospitals Foundation Trust, DH Denmark Holding ApS, Lauchchange Holding Company, Lauchchange Operations Limited and Vision Systems Pty Ltd. He serves as Deputy Chairman at Tektronix UK Holdings Ltd and Tektronix UK Ltd.

Raphael Wisniewski

Mr. Raphael Wisniewski serves as Director - Representative of Edmond de Rothschild Investment Partners at EOS Imaging SA since January 16, 2012. He joined the Life Sciences team at Edmond de Rothschild Investment Partners in 2001. He worked in Healthcare Corporate Finance at Salomon Smith Barney before joining Goldman Sachs. He also worked for the British Ministry of Health in London and in a group of hospitals, in the Finance Department. Mr. Wisniewski is a graduate of the Ecole des Hautes Etudes Commerciales. He is a Director of Poxel, Genticel, Implanet, MdxHealth, Cellnovo, Regado and Biosciences.
Search Stocks